Search Ontology:
ChEBI

fosinopril

Term ID
CHEBI:5163
Synonyms
  • (2S,4S)-4-cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid
  • (2S,4S)-4-cyclohexyl-1-{2-[(2-methyl-1-propionyloxy-propoxy)-(4-phenyl-butyl)-phosphinoyl]-acetyl}-pyrrolidine-2-carboxylic acid
  • (4S)-4-cyclohexyl-1-({[2-methyl-1-(propanoyloxy)propoxy](4-phenylbutyl)phosphoryl}acetyl)-L-proline
  • (S)-4-Cyclohexyl-1-{2-[(2-methyl-1-propionyloxy-propoxy)-(4-phenyl-butyl)-phosphinoyl]-acetyl}-pyrrolidine-2-carboxylic acid
  • fosinopril
Definition
A phosphinate ester-containing N-acyl derivative of (4S)-cyclohexyl-L-proline. It is used for the treatment of hypertension and heart failure. A pro-drug, it is hydrolysed in vivo to the corresponding phosphininc acid, fosinoprilat, which is the active metabolite.
References
  • beilstein:8176492
  • cas:98048-97-6
  • drugbank:DB00492
  • kegg.compound:C07016
  • kegg.drug:D07992
  • lincs.smallmolecule:LSM-6485
  • patent:CN101367839
  • patent:EP2264039
  • patent:US2010297711
  • patent:US4337201
  • pubmed:11937741
  • pubmed:18209565
  • pubmed:22729889
  • pubmed:8285178
  • pubmed:9195116
Ontology
ChEBI  ( EBI )
Resources
CTD
Relationships
Phenotype
Phenotype resulting from fosinopril
Phenotype where environments contain fosinopril
Phenotype modified by environments containing fosinopril
Phenotype affecting fosinopril
Human Disease Model